We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
48 hedge funds and large institutions have $160M invested in Larimar Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
26% more capital invested
Capital invested by funds: $126M → $160M (+$33.4M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9.35% less ownership
Funds ownership: 98.94% → 89.59% (-9.3%)
19% less funds holding
Funds holding: 59 → 48 (-11)
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
Holders
48
Holders Change
-11
Holders Change %
-18.64%
% of All Funds
0.77%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
20
Reduced
11
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$1.86M |
| 2 |
Millennium Management
New York
|
+$491K |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$473K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$449K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$399K |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$2.3M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.37M |
| 3 |
ACM
Altium Capital Management
New York
|
-$1.02M |
| 4 |
6CM
683 Capital Management
New York
|
-$570K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$426K |
